DAIKIN Industries, Ltd. acquired the German-based refrigerant and pharmaceutical propellant businesses from Solvay, a Belgian chemical company, in May 2015. DAIKIN Industries, Ltd. employs 56,200 people worldwide and generated EUR 13.3 billion in sales in the 2013/2014 financial year.
Its Frankfurt subsidiary has approx. 80 employees. Its main products are R134a refrigerant, R134a pharma propellant and 227 pharma propellant. Daikin also operates a unique cracking plant in Frankfurt for safely disposing of CFCs, HFCs and PFCs.